Recursion and Exscientia Enter Definitive Agreement
joint press release of 8 August 2024, filed as Exhibit 99.1 to a Recursion Form 8-K. Dateline "August 8, 2024" in the release.
- Issued by
- No issuing record yet. A missing record is a gap in coverage.
- Authors credited
- No authorship claim recorded yet. The source record lists Recursion Pharmaceuticals, Inc. and Exscientia plc (Exhibit 99.1 to Recursion Form 8-K).
- Dates
- No date claim recorded yet. The source record gives the publication date as 2024-08-08.
- Exact source
- Recursion and Exscientia Enter Definitive Agreement to Create A Global Technology-Enabled Drug Discovery Leader with End-to-End Capabilities Recursion Pharmaceuticals, Inc. and Exscientia plc (Exhibit 99.1 to Recursion Form 8-K) · published 2024-08-08 · Retrieved for the candidate pack on 2026-10-30 (SHA-256 ce47a6c63a6cc3399661915a5ec1786737ee6a5bf795795e865f1d6ebb556b22). Exhibit 99.1 to Form 8-K filed 2024-08-08, accession 0001193125-24-196505, as served by SEC EDGAR on 2026-10-30. Its wording can change; earlier wording is not authenticated.
Appears in
No collection holds a record about this document yet.
Versions
No other versions of this document are recorded. The evidence applies to the source version listed above. Other versions, such as a preprint, working paper or journal publication, are not identified or substituted.
Documentary relations
Each relation is listed separately. Citing, crediting and reporting the use of a method are different acts, and none of them shows agreement or influence by itself.
Not recorded for this document: cites · cited by · explicitly credits · reports using a method from · method reported as used by · applies parts of · parts applied by · discusses · reports evaluation of. A missing record does not show that the relation does not exist.
What the document states
A limited selection of what this document states, each with its passage. It describes the text, not whether anyone acted on it.